Recent Updates
Recently added Catalysts

ACCENDRA HEALTH INC/VA/

ACCHFDA catalysts, PDUFA dates & pipeline intelligence
$0.02
▲ +0 · +4.62%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full ACCH financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
Volume
4.68 M
Value Traded
99.18 K
Short % Float
-
+2%Week

Cash Data

Unlock ACCH cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
1.57 M
EPS (TTM)
-
P/E Ratio
-
Ent. Value
9.96 M
Total Shares
76.92 M
Float Shares
-
Insiders
-
Institutions
-

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every ACCH catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

ACCH Catalyst Timeline

Dated clinical, regulatory and corporate events for ACCENDRA HEALTH INC/VA/

Unlock the full ACCH catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How ACCH actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all ACCH historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

Unlock the ACCH pipeline intelligence model
Every scored asset with PTRS, rNPV, enrollment velocity and trial design quality.
Institutional-grade data · Cancel anytime

Clinical Trial Results

Readouts, endpoints and source filings for every ACCH program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Scroll for more · summaries link to the source press release
Unlock every ACCH trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock ACCH insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Bernocchi Perry Aformer Chief Operating OfficerSell -33,161 280,752 held$0.12 11/16/2026
Unlock the full ACCH insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
No hedge fund reported a 13F position in ACCH for Q3 2026.
Unlock every fund holding ACCH
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in ACCH
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see ACCH ownership
Insider and institutional ownership, quarter by quarter.

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2026-12-18
Unlock ACCH option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live ACCH option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock ACCH options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How ACCH ranks across every disease it competes in

Competitive Position is a premium feature
See how ACCH ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

ACCH News

About ACCENDRA HEALTH INC/VA/

BIOPHARMAWATCH ELITE
Trade the next ACCH catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime